Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Paion AG

Market Cap 144K 167K 132K 125K 234K 15.76M 236K 1.57M 611K 7.74M 627K 614K 26.76M P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 9.87M 11.44M 9.07M 8.54M 16.04M 1.08B 16.18M 108M 41.85M 530M 42.93M 42.01M 1.83B EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
90.91%
Yield 2021 *
-
Yield 2022 -
1 week-0.93%
Current month-6.19%
1 month-8.62%
3 months-24.50%
6 months+341.67%
Current year+301.52%
1 week 0.05
Extreme 0.053
0.05
1 month 0.05
Extreme 0.053
0.14
Current year 0.01
Extreme 0.012
0.23
1 year 0
Extreme 0.0002
0.23
3 years 0
Extreme 0.0001
8.52
5 years 0
Extreme 0.0001
20.3
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 2023-08-31
Director of Finance/CFO - 2022-05-31
Director TitleAgeSince
Director/Board Member 65 2012-09-30
Director/Board Member 75 2017-05-31
Director/Board Member - 2019-05-21
Date Insider Type Main position Quantity % Market Cap.
22-12-26Buy

Director

1,121 0.0016%
21-01-11Buy

Chief Executive Officer

8,500 0.0127%
20-06-07Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.93%+381.82%-99.32% 438K
-1.10%-1.04%-12.99%-11.31% 43.44B
+0.76%+9.42%+303.09%+540.82% 33.54B
-4.74%-6.31%+10.75%-20.99% 28.48B
-0.47%-0.35%+3.38%+31.20% 29.2B
+0.06%+4.36%+13.31%+21.11% 25.34B
-0.02%+10.18% - - 14.36B
-0.98%-1.86%+53.43%+106.06% 13.05B
-0.83%-3.70%+2.41%+3.27% 12.67B
+1.67%+1.35%+105.56%+81.16% 12.28B
Average -0.62%+1.01%+95.64%+72.44% 21.24B
Weighted average by Cap. -0.89%+1.35%+62.46%+105.65%

Financials

2021 2022
Net sales 7.13M 8.26M 6.55M 6.17M 11.59M 780M 11.69M 77.67M 30.24M 383M 31.01M 30.35M 1.32B 33.25M 38.54M 30.57M 28.77M 54.06M 3.64B 54.52M 362M 141M 1.79B 145M 142M 6.18B
Net income -21.79M -25.25M -20.03M -18.85M -35.43M -2.38B -35.72M -237M -92.41M -1.17B -94.78M -92.75M -4.05B -579K -671K -532K -501K -942K -63.34M -949K -6.31M -2.46M -31.09M -2.52M -2.47M -108M
Net Debt 13.77M 15.96M 12.66M 11.92M 22.39M 1.51B 22.58M 150M 58.41M 739M 59.9M 58.62M 2.56B 9.72M 11.27M 8.94M 8.41M 15.81M 1.06B 15.94M 106M 41.24M 522M 42.3M 41.4M 1.81B
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
26-06-17 0.0530 0.00% 0
26-06-16 0.0530 0.00% 0
26-06-15 0.0530 0.00% 0
26-06-12 0.0530 0.00% 0
26-06-11 0.0530 -0.93% 0
  1. Stock Market
  2. Stocks
  3. PA8K Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!